42 results
Page 2 of 3
8-K
EX-10.1
y8ebooow3l 4qjs
7 Dec 20
Entry into a Material Definitive Agreement
6:02am
8-K
EX-10.1
vgd78a 3u43k74ssw
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
EX-10.24
r6e7hu7l ic18yh
16 Mar 20
Annual report
11:09am
10-K
EX-10.23
bmk9vjcl pc8
16 Mar 20
Annual report
11:09am
10-K
EX-10.1
4475z7mdcqnpz4d16
16 Mar 20
Annual report
11:09am
8-K
EX-10.1
3j6l6
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
10-Q
EX-10.16
1xdzmk
14 Aug 19
Quarterly report
12:00am
10-Q
EX-10.20
meheo
14 Aug 19
Quarterly report
12:00am
10-Q
EX-10.21
5rjr9w84c80 5zz77vmb
14 Aug 19
Quarterly report
12:00am
8-K
EX-10.1
uxbdr6alp073tjypn
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
8-K
EX-10.1
mtpom eihn3mzkxhtz
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-10.2
p5os 1os7
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
8-K
EX-10.1
n6db6a45a1l4q
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
8-K12B
EX-10.2
ge6kowot5 1bw55l
14 Jun 19
Notification of registration of securities
5:10pm
8-K12B
EX-10.4
yk5mvmv5y
14 Jun 19
Notification of registration of securities
5:10pm